生物技术试剂盒市场 - 全球产业规模、份额、趋势、机会及预测（按试剂盒类型、技术、检测参数、微生物、应用、最终用户、地区和竞争格局划分），2021-2031年

全球生物技术试剂盒市场预计将从2025年的5.7818亿美元成长到2031年的10.4456亿美元，复合年增长率（CAGR）为10.36%。这些试剂盒包含预先包装的试剂、缓衝液和通讯协定，旨在简化和标准化生物实验，包括基因组分析、蛋白质纯化和诊断检测。推动该市场成长要素包括感染疾病和慢性病的日益增多（这些疾病需要高效的诊断流程）以及对药物研发的持续投入。根据国际药品製造商协会联合会（IFPMA）统计，2023年该产业提交了12425项国际专利申请，这表明依赖这些标准化工具的广泛研究活动的重要性。

儘管市场成长迅速，但由于严格的监管要求，仍面临许多障碍。卫生监管机构对临床级和诊断试剂盒的复杂核准程序，往往导致製造商承担高昂的财务成本，并延迟产品上市。这些监管障碍会减缓新产品交付给终端用户的速度，并阻碍成本敏感地区对专业试剂盒的采用。

市场驱动因素

生命科学领域研发投入的不断成长是全球生物技术试剂盒市场的主要驱动力。随着製药和生技公司加强探索新治疗方法，大量资金正投入标准化实验室工具的研发中，以确保实验的可重复性和效率。这些资金的涌入推动了基因组学和蛋白​​质组学试剂盒的广泛应用，而这些试剂盒对于临床前试验和早期药物发现至关重要。例如，默克公司于2024年3月发布的《2023年度报告》显示，其年度研发支出达305亿美元，显示维持创新需要巨额投资。这种研发强度也反映在监理核准的里程碑事件中。美国食品药物管理局（FDA）于2024年1月发布的《2023年新药核准报告》指出，共有55种新药核准，显示依赖这些关键试剂盒的研发活动十分活跃。

同时，感染疾病和慢性病的日益增多，迫切需要广泛采用先进的诊断和监测解决方案。癌症和心血管疾病等疾病负担的不断加重，推动了对用于生物标记检测、疾病分析和患者分层的生物技术试剂盒的需求。这些即用型试剂盒对于需要快速、准确检测且无需复杂内部製备的临床检查室至关重要。为了强调这一紧迫性，世界卫生组织（世卫组织）于2024年2月发布新闻稿，指出全球癌症负担日益加重，并估计2022年全球将新增2,000万例癌症病例。这场日益严峻的健康危机迫使医疗服务提供者和研究人员采用高通量诊断工作流程，从而确保生物技术试剂盒在学术和临床环境中持续且广泛地应用。

市场挑战

严格的监管合规和复杂的核准流程对全球生物技术试剂盒市场的成长构成了重大障碍。卫生监管机构对用于诊断或临床的试剂盒实施严格的检验标准，要求提供大量文件并经历漫长的审查週期。这些要求导致营运成本高昂，延长产品商业化週期，并迫使製造商将资源从创新转移到合规管理。因此，这种环境减缓了新技术的引入，增加了现有产品线维护的难度，并直接降低了先进研究工具到达最终用户的速度。

这种监管压力导致企业采取策略性撤出和改变打入市场策略，阻碍了整体市场扩张。当符合严格标准的成本超过潜在效益时，企业往往会延迟产品上市或完全停止某些产品的生产。根据欧洲医疗技术协会 (MedTech Europe) 2024 年的一份报告，日益增多的监管障碍导致选择欧盟作为新产品上市优先区域的领先体外诊断试剂製造商数量下降了 40%。这些趋势限制了关键地区专业试剂盒的供应，最终限制了全球产业的收入潜力和发展速度。

市场趋势

人工智慧 (AI) 和机器学习 (ML) 的融合正透过改进实验设计和数据解读，从根本上改变全球生物技术试剂盒市场。随着基因测序和蛋白质组学分析试剂盒产生日益复杂的数据集，研究人员正利用人工智慧驱动的演算法来识别模式并更准确地检验生物标记。这推动了从提供简单试剂到提供完整分析解决方案的转变。这种数位化转型正迅速成为实验室的标配，迫使製造商确保其产品与先进的运算工具相容。根据皮斯托亚联盟 (Pistoia Alliance) 2025 年 9 月发布的「未来实验室」调查，77% 的生命科学实验室计划在未来两年内使用人工智慧技术，这凸显了对支援高级数据分析的工作流程解决方案的巨大需求。

同时，市场正发生显着转变，转向液态生物检体和非侵入性诊断解决方案，推动了循环肿瘤DNA (ctDNA) 和游离DNA (cfDNA) 提取专用试剂盒的研发。由于临床上需要频繁监测患者，同时避免传统组织切片检查带来的风险，这一趋势导致对能够检测血液样本中低浓度生物标誌物的高灵敏度试剂的需求激增。这些微创检测方法的快速普及也反映在商业性绩效上。 Guardant Health于2025年10月发布的「2025财年第三季收益」新闻稿显示，其临床肿瘤检测量年增40%，反映出肿瘤诊疗流程中对血液诊断工具的依赖性日益增强。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球生物技术试剂盒市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依试剂盒类型（纯化试剂盒、扩增试剂盒、检测试剂盒、分离试剂盒等）
  • 透过技术（LAMP技术、PCR、细胞培养、定序、层析法、电泳等）
  • 依检测参数（DNA、RNA、酵素、蛋白质等）
  • 微生物（细菌、真菌、病毒等）
  • 依应用领域（现场应用与实验室应用）
  • 按最终用户（医疗保健、食品和农业、工业流程、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美生物技术试剂盒市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

7. 欧洲生物技术试剂盒市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区生物技术试剂盒市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲生物技术试剂盒市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲生物技术试剂盒市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球生物技术试剂盒市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific, Inc.
• QIAGEN NV
• Illumina, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Promega Corporation
• Takara Bio, Inc
• New England Biolabs UK Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Biotechnology Kits Market is projected to expand from USD 578.18 Million in 2025 to USD 1044.56 Million by 2031, registering a CAGR of 10.36%. These kits comprise pre-packaged sets of reagents, buffers, and protocols intended to streamline and standardize biological experiments, including genomic analysis, protein purification, and diagnostic assays. The market is chiefly driven by the rising burden of infectious and chronic diseases, which demands efficient diagnostic workflows, alongside continuous investment in pharmaceutical research and development. According to the International Federation of Pharmaceutical Manufacturers and Associations, the industry filed 12,425 international patent applications in 2023, highlighting the extensive investigative activity that depends on these standardized tools.

Despite this growth, the market faces significant obstacles due to strict regulatory compliance. The intricate approval procedures mandated by health authorities for clinical-grade and diagnostic kits often result in high financial costs and delayed market entry for manufacturers. These regulatory barriers slow the delivery of new products to end-users and can hinder the adoption of specialized kits in cost-sensitive regions.

Market Driver

Rising investments in life sciences research and development act as a primary catalyst for the Global Biotechnology Kits Market. As pharmaceutical and biotechnology companies ramp up efforts to discover new therapies, significant capital is directed toward standardized experimental tools that guarantee reproducibility and efficiency. This influx of funding supports the widespread use of genomic and proteomic kits essential for preclinical trials and early-stage drug discovery. For instance, Merck & Co.'s 'Annual Report 2023', released in March 2024, reported research and development expenses of $30.5 billion for the year, demonstrating the massive financial commitment needed to sustain innovation. This research intensity is reflected in regulatory milestones; the U.S. Food and Drug Administration's 'New Drug Therapy Approvals 2023' report from January 2024 noted the approval of 55 novel drugs, indicating high investigative activity reliant on these essential kits.

Concurrently, the increasing prevalence of infectious and chronic diseases necessitates the broad deployment of advanced diagnostic and monitoring solutions. The growing burden of conditions like cancer and cardiovascular disorders drives the demand for biotechnology kits used in biomarker detection, disease profiling, and patient stratification. These ready-to-use reagent sets are vital for clinical laboratories needing rapid, accurate assays without the complexity of in-house formulation. Underscoring this urgency, the World Health Organization's February 2024 press release on the growing global cancer burden estimated 20 million new cancer cases worldwide in 2022. This deepening health crisis compels healthcare providers and researchers to adopt high-throughput diagnostic workflows, ensuring the continuous and expanding use of biotechnology kits in both academic and clinical settings.

Market Challenge

Strict regulatory compliance and complex approval processes present a major barrier to the growth of the Global Biotechnology Kits Market. Health authorities enforce rigorous validation standards for kits intended for diagnostic or clinical use, requiring extensive documentation and lengthy review periods. These requirements create high operational costs and extend the timeline for product commercialization, forcing manufacturers to divert resources from innovation to compliance management. Consequently, this environment delays the introduction of new technologies and complicates the maintenance of existing product lines, directly reducing the speed at which advanced research tools reach end-users.

This regulatory pressure leads to strategic withdrawals and alters market entry tactics, impeding overall expansion. When the cost of meeting stringent standards outweighs potential returns, companies often delay launches or discontinue specific products entirely. According to MedTech Europe in 2024, the selection of the European Union as a priority region for new product launches by large in vitro diagnostic manufacturers declined by 40 percent due to these elevated regulatory hurdles. Such trends restrict the availability of specialized kits in major regions, ultimately limiting the revenue potential and developmental pace of the global industry.

Market Trends

The integration of artificial intelligence (AI) and machine learning (ML) is fundamentally transforming the Global Biotechnology Kits Market by improving experimental design and data interpretation. As genomic sequencing and proteomic analysis kits generate increasingly complex datasets, researchers are utilizing AI-driven algorithms to identify patterns and validate biomarkers with greater precision, moving beyond simple reagent provision to complete analytical solutions. This digital shift is rapidly becoming a standard expectation in laboratories, compelling manufacturers to ensure their products are compatible with sophisticated computational tools. According to the Pistoia Alliance's 'Lab of the Future Survey' from September 2025, 77 percent of life sciences laboratories plan to use artificial intelligence technologies within the next two years, highlighting the critical demand for workflow solutions that support advanced data analytics.

Simultaneously, there is a decisive market shift toward liquid biopsy and non-invasive diagnostic solutions, driving the development of specialized kits for circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) extraction. This trend is fueled by the clinical need for frequent patient monitoring without the risks associated with traditional tissue biopsies, creating a surge in demand for high-sensitivity reagents capable of detecting low-abundance biomarkers in blood samples. The rapid adoption of these less invasive testing modalities is evident in commercial performance; Guardant Health's 'Third Quarter 2025 Financial Results' press release from October 2025 reported a 40 percent year-over-year increase in clinical oncology test volume, reflecting the accelerating reliance on blood-based diagnostic tools in oncology workflows.

Key Market Players

• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Merck KGaA
• Promega Corporation
• Takara Bio, Inc
• New England Biolabs UK Limited

Report Scope

In this report, the Global Biotechnology Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biotechnology Kits Market, By Kit Type

• Purification Kits
• Amplification Kits
• Detection Kits
• Isolation Kits
• Others

Biotechnology Kits Market, By Technology

• LAMP Technology
• PCR
• Cell Culture
• Sequencing
• Chromatography
• Electrophoresis
• Others

Biotechnology Kits Market, By Parameter Tested

• DNA
• RNA
• Enzymes
• Proteins
• Others

Biotechnology Kits Market, By Microorganism

• Bacteria
• Fungi
• Virus
• Others

Biotechnology Kits Market, By Purpose

• On-site v/s Laboratory

Biotechnology Kits Market, By End User

• Healthcare
• Food & Agriculture
• Industrial Processing
• Others

Biotechnology Kits Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biotechnology Kits Market.

Available Customizations:

Global Biotechnology Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biotechnology Kits Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Kit Type (Purification Kits, Amplification Kits, Detection Kits, Isolation Kits, Others)
  • 5.2.2. By Technology (LAMP Technology, PCR, Cell Culture, Sequencing, Chromatography, Electrophoresis, Others)
  • 5.2.3. By Parameter Tested (DNA, RNA, Enzymes, Proteins, Others)
  • 5.2.4. By Microorganism (Bacteria, Fungi, Virus, Others)
  • 5.2.5. By Purpose (On-site v/s Laboratory)
  • 5.2.6. By End User (Healthcare, Food & Agriculture, Industrial Processing, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2025)
• 5.3. Market Map

6. North America Biotechnology Kits Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Kit Type
  • 6.2.2. By Technology
  • 6.2.3. By Parameter Tested
  • 6.2.4. By Microorganism
  • 6.2.5. By Purpose
  • 6.2.6. By End User
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biotechnology Kits Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Kit Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Parameter Tested
      • 6.3.1.2.4. By Microorganism
      • 6.3.1.2.5. By Purpose
      • 6.3.1.2.6. By End User
  • 6.3.2. Canada Biotechnology Kits Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Kit Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Parameter Tested
      • 6.3.2.2.4. By Microorganism
      • 6.3.2.2.5. By Purpose
      • 6.3.2.2.6. By End User
  • 6.3.3. Mexico Biotechnology Kits Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Kit Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Parameter Tested
      • 6.3.3.2.4. By Microorganism
      • 6.3.3.2.5. By Purpose
      • 6.3.3.2.6. By End User

7. Europe Biotechnology Kits Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Kit Type
  • 7.2.2. By Technology
  • 7.2.3. By Parameter Tested
  • 7.2.4. By Microorganism
  • 7.2.5. By Purpose
  • 7.2.6. By End User
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biotechnology Kits Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Kit Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Parameter Tested
      • 7.3.1.2.4. By Microorganism
      • 7.3.1.2.5. By Purpose
      • 7.3.1.2.6. By End User
  • 7.3.2. France Biotechnology Kits Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Kit Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Parameter Tested
      • 7.3.2.2.4. By Microorganism
      • 7.3.2.2.5. By Purpose
      • 7.3.2.2.6. By End User
  • 7.3.3. United Kingdom Biotechnology Kits Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Kit Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Parameter Tested
      • 7.3.3.2.4. By Microorganism
      • 7.3.3.2.5. By Purpose
      • 7.3.3.2.6. By End User
  • 7.3.4. Italy Biotechnology Kits Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Kit Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Parameter Tested
      • 7.3.4.2.4. By Microorganism
      • 7.3.4.2.5. By Purpose
      • 7.3.4.2.6. By End User
  • 7.3.5. Spain Biotechnology Kits Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Kit Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Parameter Tested
      • 7.3.5.2.4. By Microorganism
      • 7.3.5.2.5. By Purpose
      • 7.3.5.2.6. By End User

8. Asia Pacific Biotechnology Kits Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Kit Type
  • 8.2.2. By Technology
  • 8.2.3. By Parameter Tested
  • 8.2.4. By Microorganism
  • 8.2.5. By Purpose
  • 8.2.6. By End User
  • 8.2.7. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biotechnology Kits Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Kit Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Parameter Tested
      • 8.3.1.2.4. By Microorganism
      • 8.3.1.2.5. By Purpose
      • 8.3.1.2.6. By End User
  • 8.3.2. India Biotechnology Kits Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Kit Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Parameter Tested
      • 8.3.2.2.4. By Microorganism
      • 8.3.2.2.5. By Purpose
      • 8.3.2.2.6. By End User
  • 8.3.3. Japan Biotechnology Kits Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Kit Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Parameter Tested
      • 8.3.3.2.4. By Microorganism
      • 8.3.3.2.5. By Purpose
      • 8.3.3.2.6. By End User
  • 8.3.4. South Korea Biotechnology Kits Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Kit Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Parameter Tested
      • 8.3.4.2.4. By Microorganism
      • 8.3.4.2.5. By Purpose
      • 8.3.4.2.6. By End User
  • 8.3.5. Australia Biotechnology Kits Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Kit Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Parameter Tested
      • 8.3.5.2.4. By Microorganism
      • 8.3.5.2.5. By Purpose
      • 8.3.5.2.6. By End User

9. Middle East & Africa Biotechnology Kits Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Kit Type
  • 9.2.2. By Technology
  • 9.2.3. By Parameter Tested
  • 9.2.4. By Microorganism
  • 9.2.5. By Purpose
  • 9.2.6. By End User
  • 9.2.7. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biotechnology Kits Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Kit Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Parameter Tested
      • 9.3.1.2.4. By Microorganism
      • 9.3.1.2.5. By Purpose
      • 9.3.1.2.6. By End User
  • 9.3.2. UAE Biotechnology Kits Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Kit Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Parameter Tested
      • 9.3.2.2.4. By Microorganism
      • 9.3.2.2.5. By Purpose
      • 9.3.2.2.6. By End User
  • 9.3.3. South Africa Biotechnology Kits Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Kit Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Parameter Tested
      • 9.3.3.2.4. By Microorganism
      • 9.3.3.2.5. By Purpose
      • 9.3.3.2.6. By End User

10. South America Biotechnology Kits Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Kit Type
  • 10.2.2. By Technology
  • 10.2.3. By Parameter Tested
  • 10.2.4. By Microorganism
  • 10.2.5. By Purpose
  • 10.2.6. By End User
  • 10.2.7. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biotechnology Kits Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Kit Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Parameter Tested
      • 10.3.1.2.4. By Microorganism
      • 10.3.1.2.5. By Purpose
      • 10.3.1.2.6. By End User
  • 10.3.2. Colombia Biotechnology Kits Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Kit Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Parameter Tested
      • 10.3.2.2.4. By Microorganism
      • 10.3.2.2.5. By Purpose
      • 10.3.2.2.6. By End User
  • 10.3.3. Argentina Biotechnology Kits Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Kit Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Parameter Tested
      • 10.3.3.2.4. By Microorganism
      • 10.3.3.2.5. By Purpose
      • 10.3.3.2.6. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biotechnology Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. QIAGEN N.V.
• 15.3. Illumina, Inc.
• 15.4. Agilent Technologies, Inc.
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. F. Hoffmann-La Roche AG
• 15.7. Merck KGaA
• 15.8. Promega Corporation
• 15.9. Takara Bio, Inc
• 15.10. New England Biolabs UK Limited

16. Strategic Recommendations

17. About Us & Disclaimer